This will play a video. - Illustration of catheter ablation procedure

Medtronic cardiac ablation solutions For Atrial Fibrillation Ablation

ARCTIC FRONTTM FAMILY OF cardiac cryoablation catheters

One method for treating atrial fibrillation (AF) is cryoablation using the Arctic FrontTM family of cardiac cryoablation catheters. The cryoablation catheters deliver a refrigerant through an inflatable balloon to freeze tissue and disable unwanted electrical signals triggering your AF.

The Arctic FrontTM family of cryoablation catheters are safe, effective and efficient medical devices for treating AF.1-2 Because of their balloon shape, the catheters allow physicians to reach and treat pulmonary veins (the site of unwanted electrical currents which trigger your AF) quickly and efficiently. Many patients treated with the Arctic FrontTM family of cryoablation catheters experience a welcome improvement in their quality of life as unpleasant symptoms such as shortness of breath, fatigue, and weakness lessen or disappear. 

More than 500,000 patients have been treated with the Arctic FrontTM family of cryoablation catheters.3

Learn more about the cryoballoon procedure

DIAMONDTEMPTM ABLATION SYSTEM

AF may also be treated using a radiofrequency (RF) ablation catheter, which uses heat to protect your heart from  unwanted electrical signals that trigger and maintain AF.

The DiamondTemp™ Abaltion System is Medtronic’s novel technology. It uses radiofrequency (RF) energy (heat) to safely and effectively block irregular signals in the heart causing the abnormal heartbeat.4

Learn more about the radiofrequency procedure

1

Kuck KH, FürnkranzA, Chun KR, et al. FIRE AND ICE trial. European Heart Journal 2016;37:2858-65.

2

Wazni, O., et al. Safety and Efficacy of cryoballoon catheter ablation as a first line treatment for patients with paroxysmal atrial fibrillation: primary results of the randomized STOP AF First study. New England Journal of Medecine. 2020.

3

Medtronic data on file.

4

Kautzner J, et al. Results of the DIAMOND-AF Trial. Presented at APHRS 2020 Virtual Congress, October 2020.

Brief Statement

This information is intended only for users in markets where Medtronic products and therapies are approved or available for use as indicated within the respective product manuals. Content on specific Medtronic products and therapies is not intended for users in markets that do not have authorisation for use.

See the device manual(s) for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events.